TIDMUDG

RNS Number : 7376U

UDG Healthcare Public Limited Co.

16 July 2018

16 July 2018

UDG Healthcare plc

Notice of Q3 2018 Trading Update

UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the third quarter to 30 June 2018 at 7.00am (BST) on Wednesday 8 August 2018.

The Company will also host a conference call for investors and analysts at 9:00am (BST) on Wednesday 8 August 2018 to discuss the statement. The dial-in details are as follows:

 
 International Access    +44 (0) 203 936 1888 
 UK Local Access         0203 936 1888 
                        --------------------- 
 Ireland Local Access    0155 30187 
                        --------------------- 
 USA Local Access        16469680351 
                        ---------------------

A playback facility will be available for seven days on 0203 936 1888. The access code for the replay will be 517509

For further information, please contact:

Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000

Lisa Kavanagh / Jana Tsiligiannis

Powerscourt

Tel: +44-207-250-1446

Email: udghealthcare@powerscourt-group.com

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 9,000 people with operations in 25 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries.

It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of-the-art facilities in the US and Europe.

Aquilant is a leading provider of outsourced sales, marketing, engineering and distribution services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCRFMLTMBBBMTP

(END) Dow Jones Newswires

July 16, 2018 05:16 ET (09:16 GMT)

Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Udg Healthcare Public Charts.
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Udg Healthcare Public Charts.